Combined treatment with ceftriaxone and linezolid of pneumococcal meningitis: a case series including penicillin-resistant strains

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
F FaellaM Conte

Abstract

This study evaluated the role of linezolid in the treatment of patients suffering from pneumococcal meningitis. Treatment included ceftriaxone (4000 mg every 24 h), linezolid (600 mg every 12 h) and dexamethasone (8 mg every 6 h). Linezolid was withdrawn if a penicillin-susceptible isolate of Streptococcus pneumoniae was identified. Of 16 patients studied, seven were infected with penicillin-non-susceptible isolates of S. pneumoniae, two died, and three reported sequelae. No toxicity was reported. It was concluded that linezolid can be used for the treatment of pneumococcal meningitis, as an alternative to vancomycin or rifampicin, in regimens including a third-generation cephalosporin.

References

May 1, 1988·The Journal of Antimicrobial Chemotherapy·W M DanknerS A Spector
Jul 13, 1974·Lancet·G Teasdale, B Jennett
Nov 30, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A PantostiP Mastrantonio
Jan 3, 2001·The New England Journal of Medicine·C G WhitneyUNKNOWN Active Bacterial Core Surveillance Program of the Emerging Infections Program Network
Jul 20, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C ZeanaS M Hammer
Aug 30, 2001·Archives of Internal Medicine·G W WatererR G Wunderink
Sep 11, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P M van TilburgP W Hermans
Feb 19, 2002·Antimicrobial Agents and Chemotherapy·P VillaniR Bergomi
Oct 18, 2002·Antimicrobial Agents and Chemotherapy·D AndesW A Craig
Nov 15, 2002·The New England Journal of Medicine·Jan de GansUNKNOWN European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators
Jan 11, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Mary C BirminghamJerome J Schentag
Mar 7, 2003·The New England Journal of Medicine·Jeffrey A Tabas, Henry F Chambers
Feb 10, 2004·Journal of Clinical Microbiology·Wolfgang A KruegerKlaus E Unertl
May 6, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Eric L Nuermberger, William R Bishai
Oct 21, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Allan R TunkelRichard J Whitley
Oct 29, 2004·The New England Journal of Medicine·Morton N Swartz

❮ Previous
Next ❯

Citations

Apr 14, 2007·Intensive Care Medicine·Paula RamírezJuan M Bonastre
Aug 27, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·L SiiraA Virolainen
Apr 25, 2012·International Journal of Clinical Pharmacy·Christopher J A DuncanR Andrew Seaton
Jul 13, 2012·Infection and Drug Resistance·Sally Ager, Kate Gould
Oct 18, 2011·Paediatric Drugs·Shruti Agrawal, Simon Nadel
Feb 7, 2008·Expert Review of Anti-infective Therapy·William J PeppardAngela M Urmanski
Jul 25, 2009·Expert Opinion on Emerging Drugs·Ala-Eddine DeghmaneMuhamed-Kheir Taha
May 12, 2009·Médecine et maladies infectieuses·P Chavanet
Sep 19, 2012·Expert Opinion on Pharmacotherapy·Seon Hee Shin, Kwang Sik Kim
Jun 16, 2011·Scandinavian Journal of Infectious Diseases·Oguz Resat SipahiSercan Ulusoy
Nov 12, 2013·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Hakan ErdemHaluk Vahaboglu
Jul 11, 2020·Infectious Diseases·Vicente PintadoElisa Pérez-Cecilia
Feb 8, 2007·The Annals of Pharmacotherapy·Fotinie Ntziora, Matthew E Falagas
Sep 20, 2007·FEMS Immunology and Medical Microbiology·Pasquale PaglianoFrancesco Saverio Faella
Sep 20, 2017·Wiener medizinische Wochenschrift·Mahtab BeitdagharFereshteh Saffari
Mar 20, 2008·Farmacia hospitalaria : órgano oficial de expresión científica de la Sociedad Española de Farmacia Hospitalaria·P M Olaechea AstigarragaUNKNOWN INfectious Diseases Working Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
C ZeanaS M Hammer
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Allan R TunkelRichard J Whitley
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
Cynthia M GerberP Cottagnoud
© 2021 Meta ULC. All rights reserved